These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21047978)

  • 1. Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group.
    Cooper A; van Doorninck J; Ji L; Russell D; Ladanyi M; Shimada H; Krailo M; Womer RB; Hsu JH; Thomas D; Triche TJ; Sposto R; Lawlor ER
    Clin Cancer Res; 2011 Jan; 17(1):56-66. PubMed ID: 21047978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression.
    Douglas D; Hsu JH; Hung L; Cooper A; Abdueva D; van Doorninck J; Peng G; Shimada H; Triche TJ; Lawlor ER
    Cancer Res; 2008 Aug; 68(16):6507-15. PubMed ID: 18701473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma.
    Hsu JH; Lawlor ER
    Oncogene; 2011 Apr; 30(17):2077-85. PubMed ID: 21170084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/Frizzled signaling in Ewing sarcoma.
    Uren A; Wolf V; Sun YF; Azari A; Rubin JS; Toretsky JA
    Pediatr Blood Cancer; 2004 Sep; 43(3):243-9. PubMed ID: 15266408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.
    van Doorninck JA; Ji L; Schaub B; Shimada H; Wing MR; Krailo MD; Lessnick SL; Marina N; Triche TJ; Sposto R; Womer RB; Lawlor ER
    J Clin Oncol; 2010 Apr; 28(12):1989-94. PubMed ID: 20308669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133 expression in chemo-resistant Ewing sarcoma cells.
    Jiang X; Gwye Y; Russell D; Cao C; Douglas D; Hung L; Kovar H; Triche TJ; Lawlor ER
    BMC Cancer; 2010 Mar; 10():116. PubMed ID: 20346143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors.
    Savola S; Klami A; Tripathi A; Niini T; Serra M; Picci P; Kaski S; Zambelli D; Scotlandi K; Knuutila S
    BMC Cancer; 2009 Jan; 9():17. PubMed ID: 19144156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
    Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
    Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Bmi-1 is a prognostic marker in bladder cancer.
    Qin ZK; Yang JA; Ye YL; Zhang X; Xu LH; Zhou FJ; Han H; Liu ZW; Song LB; Zeng MS
    BMC Cancer; 2009 Feb; 9():61. PubMed ID: 19228380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.
    Zhang X; Wang CX; Zhu CB; Zhang J; Kan SF; Du LT; Li W; Wang LL; Wang S
    Int J Gynecol Cancer; 2010 Dec; 20(9):1597-603. PubMed ID: 21370603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.
    Engelsen IB; Mannelqvist M; Stefansson IM; Carter SL; Beroukhim R; Øyan AM; Otte AP; Kalland KH; Akslen LA; Salvesen HB
    Br J Cancer; 2008 May; 98(10):1662-9. PubMed ID: 18475299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer.
    Riis ML; Lüders T; Nesbakken AJ; Vollan HS; Kristensen V; Bukholm IR
    BMC Cancer; 2010 Dec; 10():686. PubMed ID: 21162745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
    Silva J; García JM; Peña C; García V; Domínguez G; Suárez D; Camacho FI; Espinosa R; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2006 Dec; 12(23):6929-36. PubMed ID: 17145810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16Ink4a suppression of lung adenocarcinoma by Bmi-1 in the presence of p38 activation.
    Lee MO; Lee HJ; Kim MA; Kim EK; Lee JH; Heo JH; Lee SH; Cho SH; Fornace AJ; Jeong HC; Cha HJ
    J Thorac Oncol; 2011 Mar; 6(3):423-31. PubMed ID: 21164364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients.
    Silva J; García V; García JM; Peña C; Domínguez G; Díaz R; Lorenzo Y; Hurtado A; Sánchez A; Bonilla F
    Breast Cancer Res; 2007; 9(4):R55. PubMed ID: 17711569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients.
    Choi YJ; Choi YL; Cho EY; Shin YK; Sung KW; Hwang YK; Lee SJ; Kong G; Lee JE; Kim JS; Kim JH; Yang JH; Nam SJ
    Breast Cancer Res Treat; 2009 Jan; 113(1):83-93. PubMed ID: 18228133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor.
    Athale UH; Shurtleff SA; Jenkins JJ; Poquette CA; Tan M; Downing JR; Pappo AS
    J Pediatr Hematol Oncol; 2001 Feb; 23(2):99-104. PubMed ID: 11216714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma.
    Puls F; Niblett A; Marland G; Gaston CL; Douis H; Mangham DC; Sumathi VP; Kindblom LG
    Am J Surg Pathol; 2014 Oct; 38(10):1307-18. PubMed ID: 24805859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.
    Mendiola M; Carrillo J; García E; Lalli E; Hernández T; de Alava E; Tirode F; Delattre O; García-Miguel P; López-Barea F; Pestaña A; Alonso J
    Int J Cancer; 2006 Mar; 118(6):1381-9. PubMed ID: 16206264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.